cerrar
Tagged with strategy

Interview: Adrian Grecu – General Manager, Mylan Romania
The general manager of one of the world's largest API manufacturers recalls the recent acquisition of Abbott by Mylan and the processes which he has…

Interview: Jung Hyun Ho – Founder & CEO, Medytox – Korea
Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow…

Interview: Mark Stoffels – General Manager, Philips Healthcare…
Philips aims at becoming the leading provider of solutions across the full ‘continuum of care’. The general manager of the healthcare division in…

Plan Remediar – Mauricio Monsalvo, National Coordinator…
The national coordinator for Argentina’s ministry of health Plan Remediar discusses developing a professional management culture in the country’s…

Janssen Latin America South – Alejandro Smolje, Finance…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how…

Interview part two: Rongjin Lin, Chairman, TTY Biopharm, Taiwan
In the second part of this two-part interview, the chairman of TTY looks back at his experiences in the Taiwanese market, and assess what could have…

Mohammed Zafrullah – VP & GM GCC & Levant, GSK…
Mohammed Zafrullah, VP & General Manager of GlaxoSmithKline (GSK) Pharmaceuticals, argues that the UAE, despite recent turmoil in the rest of the…

Jan van der Goten, Managing Director GCC, Janssen, UAE
Jan van der Goten, GCC Managing Director of Janssen UAE, talks about his experience at Janssen GCC as regional manager, how collaboration with other…

Paolo Carli – Head of Middle East, KSA & Egypt, Merck…
Paolo Carli, Head of Middle East, KSA & Egypt for Merck Serono, speaks about the regions most pressing health issues—hypertension and…

Is there a future for MNCs in Mexico?
With the use of generics on the rise in Mexico, thanks to the implementation of Seguro Popular, the country's social security program, PharmaBoardroom…

Interview: Barry Fishman, President & CEO, Teva Canada
The president & CEO of Canada’s largest generics player considers the current market dynamics for generic products, including IP regulation,…

Interview: Ming-Chu Hsu, Chairman & CEO, TaiGen…
TaiGen is on the brink of releasing Taiwan’s first innovative drug. In this interview, the Chairman and CEO of the company discusses the development…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here